Cella Medical Solutions

Cella Medical Solutions

Barcelona, Spain· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Cella Medical Solutions is a Barcelona-based provider of a software-as-a-service (SaaS) platform for 3D surgical planning, primarily for complex soft tissue surgeries in areas like hepatobiliary, urological, thoracic, and pediatric surgery. The company leverages advanced medical image segmentation, multimodal fusion (CT, MRI, PET), and clinical validation by radiologists to deliver interactive 3D models used in over 15,000 surgeries. It operates a service-based business model, integrating with hospital RIS/PACS systems and offering tools for pre-operative planning and intra-operative guidance, aiming to reduce surgical times, complications, and hospital costs.

Surgical OncologyHepatobiliary SurgeryUrological SurgeryThoracic SurgeryPediatric SurgeryGeneral Surgery

Technology Platform

Cloud-based SaaS platform for creating patient-specific 3D anatomical models from medical images (CT, MRI, PET). Combines advanced image segmentation, multimodal fusion, AI/radiomics algorithms, and clinical validation by radiologists. Provides web-based surgical planning tools and intra-operative guidance integration.

Opportunities

The global shift towards value-based healthcare and precision surgery creates strong demand for tools that improve outcomes and reduce costs.
Expansion into new surgical specialties (cardiac, pediatric) and geographic markets (Europe, LatAm) presents significant growth potential.
Partnerships with surgical robotics companies could provide a powerful channel for distribution and integration.

Risk Factors

Facing competition from large medtech companies and startups in the digital surgery space.
Scaling the service model, which combines technology with expert human validation, presents operational challenges.
Navigating diverse healthcare reimbursement landscapes for software-as-a-medical-device can slow adoption.

Competitive Landscape

Competitors include large medical device companies with digital surgery divisions (e.g., Medtronic's Touch Surgery, Stryker's NAV3i), specialized 3D imaging software firms (e.g., Materialise, Visible Patient), and startups in the AI-powered surgical planning space. Cella differentiates through its deep focus on validated, high-precision models for complex soft tissue surgery and its integrated clinical support model.